HLA-DRB1 and -DQB1 loci in three west African ethnic groups: Genetic relationship with sub-Saharan African and European populations

The Fulani of west Africa have been shown to be less susceptible to malaria and to mount a stronger immune response to malaria than sympatric ethnic groups. The analysis of HLA diversity is useful for the assessment of the genetic distance between the Fulani and sympatric populations, which represents the necessary theoretical background for the investigation of genetic determinants of susceptibility to malaria. We assessed the polymorphism of HLA-DRB1 and -DQB1 loci and analyzed the distribution of alleles/haplotypes in Fulani, Mossi, and Rimaibé from Burkina Faso. We then investigated the genetic relationship of these three ethnic groups with other sub-Saharan African populations as well as with Europeans. We confirmed that the Fulani from Burkina Faso are genetically distinct from sympatric Mossi and Rimaibé. Furthermore the Fulani from Burkina Faso are close to those from The Gambia and, intriguingly, share the distribution of specific alleles with east African populations (Amhara and Oromo). It is noteworthy that the HLA-DRB1*04 and -DQB1*02 alleles, which are implicated in the development of several autoimmune diseases, are present at high frequency in the Fulani, suggesting their potential involvement in the enhanced immune reactivity observed in this population.     

HLA -A, -C, -B, -DRB1, -DQB1 and -DPB1 allele and haplotype frequencies in 4514 healthy Norwegians

We report HLA-A, -C, -B, -DRB1, -DQB1 and -DPB1 allele frequencies and estimated haplotype frequencies from 4514 healthy Norwegians who volunteered to participate in the Norwegian Bone Marrow Donor Registry. HLA genotyping was conducted on a Next Generation Sequencing platform. Data were analyzed using Arlequin and Pypop software. No significant deviations from Hardy-Weinberg Equilibrium were noted at any of the loci studied. We discuss the representability for the Norwegian population and argue that the presented HLA data could serve as a Norwegian reference panel.     

HLA-DRB1、DQB1基因与汉族人群寻常型天疱疮的相关性研究

目的　探讨 HL A- DRB1、DQB1位点基因在汉族人群寻常型天疱疮易感性中的作用。方法用序列特异性引物 -聚合酶链反应方法 ,对 6 1例寻常型天疱疮 (pemphigus vulgaris,PV)患者和 5 7名正常对照进行了 HL A- DRB1、DQB1等位基因的分型 ,并分析了 DRB1、DQB1基因在两组中的分布。结果　与正常对照组比较 ,PV组 DR4、DRB1* 14 (* 14 0 1、* 14 0 4、* 14 0 5 )基因频率明显增高 (Pc分别 <0 .0 5及P<0 .0 1) ,差异有显著性 ;PV组 DQB1* 0 5 0 3、DQB1* 0 30 2基因频率明显增高 (Pc均 <0 .0 5 ) ,差异有显著性。对 DR4阳性样本的组内基因亚型分型结果发现 ,PV组中 DRB1* 0 4 0 3、DRB1* 0 4 0 6频率显著增高(Pc<0 .0 5 ) ,差异有显著性。 PV患者组单倍型 HL A- DRB1* 0 4 ,DQB1* 0 30 2和 HL A- DRB1* 14 ,DQB1* 0 5 0 3频率明显增高 (P<0 .0 5 )。结论　HL A- DRB1* 0 4 ,DQB1* 0 30 2和 HL A- DRB1* 14 ,DQB1* 0 5 0 3可能是汉族人 PV推测的易感单倍型。     

The search for HLA-matched donors: a summary of HLA-A*, -B*, -DRB1/3/4/5* alleles and their association with serologically defined HLA-A, -B, -DR antigens

This report summarizes data obtained from several large studies including the WHO HLA Nomenclature Committee, the International Cell Exchange, UCLA, the British Society for Histocompatibility and Immunogenetics Rare Cell Exchange and the National Marrow Donor Program and individual laboratories aimed at identifying a serologic type for specific HLA-A,-B,-DRB allelic products. Alleles that are poorly characterized at the serologic level are indicated and an approach is suggested for obtaining the information needed to clarify their serologic typing. The tables provided will be useful in guiding searches for an unrelated donor in which patient and/or potential donors are typed either by serology or by DNA-based methods and will provide a "dictionary" of potential equivalents between HLA "types" obtained by the two methods.     

HLA-A, -B, -C, -DRB1 and -DQB1 allele and haplotype frequencies in a population of 432 healthy unrelated individuals from Albania

This paper reports the HLA-A, -B, -C, -DRB1 and -DQB1 allele and haplotype polymorphism in a population of 432 healthy individuals from Albania. First-field HLA genotyping was performed by polymerase chain reaction sequence-specific priming and/or oligonucleotide methods. The data were analyzed statistically using gene counting and Arlequin software packages. No deviation from Hardy Weinberg Equilibrium was detected at any of the loci studied. The HLA genotypic data of the population sample reported here are available publicly in the Allele Frequencies Net Database and they can serve as a reference database for further HLA-based population genetics studies including the Albanian population.     

HLA-DRB1*07与慢性乙肝患者Th1/Th2因子表达水平的相关性

目的 :探讨广东地区汉族慢性乙型肝炎患者HLA DRB1 0 7与Th1 Th2因子表达水平的相关性。方法 :收集 12 0例广东地区汉族慢性乙肝患者新鲜抗凝血各 8ml,通过序列特异性引物套式PCR(PCR SSP)方法进行HLA DRB1 0 7检测 ,并同时用双抗体夹心法检测患者治疗前后外周血CD4 +T细胞分泌IFN γ、IL 2、IL 10和IL 4的水平。结果 :12 0例慢性乙肝患者HLA DRB1 0 7携带者 31例 ,携带率为 2 5 8% ,明显高于广东地区汉族人群的平均携带率 7 84 % ;HLA DRB1 0 7阳性患者IFN γ平均表达水平为 (1132 0 4± 75 36 )pg ml,IL 2平均表达水平为 (1184 0 6± 81 4 2 )pg ml,IL 4平均表达水平为 (876 79± 4 7 5 3)pg ml,IL 10平均表达水平为 (817 4 8± 2 4 4 0 )pg ml ;HLA DRB1 0 7阴性患者IFN γ平均表达水平为 (12 32 10± 198 13)pg ml,IL 2平均表达水平为 (12 0 8 17± 116 12 )pg ml,IL 4平均表达水平为 (6 81 99± 6 1 5 9)pg ml,IL 10平均表达水平为 (6 38 84± 76 17)pg ml。HLA DRB1 0 7阳性患者IL 4、IL 10表达水平高于阴性患者 (P <0 0 5 ) ,而IFN γ、IL 2表达水平与阴性患者差异无统计学意义 (P >0 0 5 )。结论 :HLA DRB1 0 7(+)慢性乙肝患者Th2因子表达水平高于HLA DRB1 0 7(- )慢性乙肝患者。     

HLA DRB1-DQA1-DQB1 haplotype diversity in two African populations

HLA class II DRB1-DQA1-DQB1 haplotypic polymorphism was determined in 120 Liberian and 230 Gabonese individuals. In our study groups, the number of allelic variants observed for each locus was similar to that found in non-African populations. However, 39 novel haplotypes and several yet unrecognized DRB1-DQA1 and DQA1-DQB1 combinations were identified. The extent of HLA-haplotypic variability in Africans appears to result from the high degree of allele combinations rather than from allelic polymorphism.     

用PCR-SSP方法研究广西壮族HLA-DQA1和B1基因多态性

目的　检测广西壮族ＨＬＡＤＱＡ１ ,Ｂ１ 基因的多态性。方法　应用ＰＣＲＳＳＰ 方法对１４０ 名健康、无血缘关系广西壮族人的ＨＬＡＤＱＡ１ 和ＤＱＢ１ 进行基因分型。结果　共检出７ 个ＤＱＡ１ 等位基因和１６ 个ＤＱＢ１ 等位基因。在检出的ＤＱＡ１ 等位基因中,０３０１ 的基因频率最高（３５ ％ ） ,０４０１ 的基因频率最低（１ ．１ ％ ） 。在ＤＱＢ１ 等位基因中,０６０１（２２ ．１ ％ ） ,０３０１（２０ ．７ ％ ） ,０５０１（１３ ．９ ％ ） 最为常见。未检出的等位基因包括ＨＬＡＤＱＡ１ ＊ ０２０１ ,０３０２ ,０６０１ ,ＤＱＢ１ ＊ ０６０３ ,０６０５ 和０６０８ 。结论　广西壮族ＨＬＡＤＱＡ１ ,Ｂ１ 基因的多态性不仅有中华民族的特点,而且也有其独特性。     

The HLA dictionary 1999: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens

This report presents serologic equivalents of 90 HLA-A, 190 HLA-B and 145 HLA-DRB1 alleles. The equivalents cover over 70% of the presently identified HLA-A, -B and -DRB1 alleles. The dictionary is an update of the one published in 1997 and now also includes equivalents for HLA-C, DRB3, DRB4, DRB5 and DQB1 alleles. The data summarize information obtained by the WHO HLA Nomenclature Committee, the International Cell Exchange (UCLA), the National Marrow Donor Program (NMDP) and by individual laboratories. In addition, a listing is provided of alleles which are expressed as antigens with serologic reaction patterns that differ from the well-established HLA specificities and that often lack official WHO nomenclature. The provided equivalents will be useful in guiding searches for unrelated donors in which patients and/or potential donors are typed by either serology or DNA-based methods. These equivalents will also serve typing and matching procedures for organ transplant programs where HLA typings from donors and from recipients on waiting lists represent mixtures of serologic and molecular typings. Some guidelines are provided for the use of appropriate WHO HLA nomenclature for serological typings and for generic and allele specific typings obtained with molecular methods. The tables with HLA equivalents and the questionnaire for submission of serology on poorly identified alleles will also be available at the WMDA web page: www:bmdw.org/wmda.     

The HLA Dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens

This report presents the serologic equivalents of 123 HLA-A, 272 HLA-B and 155 HLA-DRB1 alleles. The equivalents cover over 64% of the presently identified HLA-A, -B and -DRB1 alleles. The dictionary is an update of the one published in 1999 and also includes equivalents for HLA-C, DRB3, DRB4, DRB5 and DQB1 alleles. The data summarize information obtained by the WHO Nomenclature Committee for Factors of the HLA System, the International Cell Exchange (UCLA), the National Marrow Donor Program (NMDP) and individual laboratories. In addition, a listing is provided of alleles which are expressed as antigens with serologic reaction patterns that differ from the well-established HLA specificities. The equivalents provided will be useful in guiding searches for unrelated hematopoietic stem cell donors in which patients and/or potential donors are typed by either serology or DNA-based methods. These equivalents will also serve typing and matching procedures for organ transplant programs where HLA typings from donors and from recipients on waiting lists represent mixtures of serologic and molecular typings. The tables with HLA equivalents and a questionnaire for submission of serologic reaction patterns for poorly identified allelic products will also be available on the WMDA web page: http://www.worldmarrow.org.     

New HLA-DRB1*07 allele identified from microlymphocytotoxicity/SSP discrepancies

A HLA-DRB1*07 variant allele has been identified in a cadaver kidney donor. Serological typing using monoclonal antibodies detected HLA-DR4 and HLA-DR7. HLA class II DNA typing using sequence-specific primer (PCR-SSP) polymerase chain reaction only detected DRB1*04, while sequence-specific oligonucleotide (PCR-SSO) polymerase chain reaction confirmed the presence of both DRB1*04 and DRB1*07 alleles, although two extra reactions were also found. Exon 2 of the HLA-DRB1*07 was isolated using allele-specific PCR, then cloned and sequenced. Four mutations, at positions 170 (T --> C), 171 (C --> T), 174 (C --> G), and 179 (C --> A), were observed. These mutations changed codons 57 and 60 (V --> A; S --> Y, respectively). This amino acid sequence at position 56-61 is only found in DRB1*0811.     

云南大理白族HLA-DRB1、-DQB1等位基因多态性分析

目的:了解白族人群人类白细胞抗原(Human leukocyte antigen,HLA) Ⅱ类基因-DRB1、-DQB1位点的遗传多态性.方法:采用PCR-SSP方法对124名云南大理洱源白族健康个体进行HLA-DRB1、-DQB1等位基因分型.结果:共检出21种DRB1等位基因,15种DQB1等位基因.其中主要的等位基因有DRB1*1202(26.61%)、DRB1*0901(13.89%)、DRB1*0803(9.92%)、DQB1*0301(31.45%)、DQB1*0601(10.08%)和DQB1*0401(8.06%).主要单倍型包括DRB1*1202-DQB1*0301(20.08%)和DRB1*0803-DQB1*0601(7.19%).结论:大理白族同其他10个民族群体HLA-DRB1、DQB1频率比较和聚类分析显示大理白族属于中国南方人群,但与其他群体存在一定的遗传距离,有着独特的HLA基因特性,对群体遗传及疾病相关性研究具有参考意义.     

A novel HLA-DQA1 allele,DQA1*01042

We have identified a novel HLA-DQA1 allele in the homozygous cell line KGV (I HW9309) derived from a Caucasoid individual from the Indian subcontinent. This novel allele, DQA1*01042, differs from the DQA1*01041 allele by a single synonymous substituition within exon 3, position 438A-->C.1     

Human leukocyte antigen class I (A,B, C) and class II (DPB1, DQB1, DRB1) allele and haplotype variation in Black South African individuals

South Africa has a population of 58.78 million, of which 80.7% are Black African individuals, representing 9 predominant ethnic/linguistic groups (Zulu, Xhosa, Pedi, Tswana, South Sotho, Tsonga, Swati, Venda and Ndebele). HIV-1 and Mycobacterium tuberculosis infection are the leading causes of death (7.8% and 5.9%, respectively) in this population group. To provide reference HLA allele and haplotype data for studies of gene-associations with infectious/non-infectious diseases or vaccine development, we have updated previously published HLA class I (A, B, C) and class II DRB1 genotypes and determined high-resolution class II (DPB1, DQB1) genotypes for n = 142 healthy, unrelated Black South African individuals.     

Association of TNF-α genetic polymorphism with HLA DPB1*0301

BACKGROUND: We speculated TNF-alpha can be one of candidate gene for aspirin-intolerant asthma (AIA) because TNF-alpha is pro-inflammatory cytokine and known to be increased level in asthmatic airways. In addition, genetic interaction between TNF-alpha and human antigen leucocyte (HLA) DPB1*0301, which is a strong genetic marker for AIA, was examined for its close location within chromosome 6. METHOD: To investigate genetic association of TNF-alpha with an AIA phenotype, three study groups (163 patients with AIA, 197 patients with aspirin-tolerant asthma (ATA), 257 normal control subjects) were enrolled. Single nucleotide polymorphisms (SNPs) were genotyped using a single-base extension method and HLA DPB1 genotyping was determined by high-throughput sequencing method. RESULTS: All five SNPs of TNF-alpha were tested; there were no significant differences in allele and genotype frequencies among the three groups. However, significant association between TNF-alpha-308G>A polymorphism and atopy status was noted (P<0.05). Gene to gene interaction between TNF-alpha-1031T>C (or -863C>A or -857C>A) and HLA DPB1*0301could synergistically increase the susceptibility to AIA with odds ratio (OR) to 7.738 (or OR=8.184 for -863C>A, OR=7.500 for -857C>T, P<0.001, respectively). CONCLUSION: TNF-alpha promoter polymorphism may significantly increase susceptibility to AIA by gene-to-gene interaction with HLA DPB1*0301.     

A novel HLA-DRB1 sequence, DRB1*11272

We describe the complete exon 2 sequence of a novel HLA-DRB1 allele, DRB1*11272. This allele differs from the DRB1*11271 allele by a synonymous mutation in codon 77 where an AAT is replaced with AAC, both encode for the amino acid asparagine. The same motif at codon 77 has also been found in DRB1*1107, DRB1*1333, DRB1*0422 and in most DRB1*03 alleles. A partial exon 2 sequence of this allele has previously been deposited in the EMBL Sequence Database under the accession number AF186407.     

山东地区汉族人 HLA-DPB1基因单核苷酸多态性

使用第十一届国际组织相容性会议提供的HLA－DPB1引物序列，由PCR技术扩增人HLA－DPB1基因第二外显子。产物纯化后，直接核酸序列分析确定个体的HLA－DPB1外显子核酸序列。使用基因定型软件与国际上公布的HLA－DPB1核酸序列构建的基因型核酸序列数据库进行比较，确定个体的基因型别、确定等位基因类型。研究结果提示中国人HLA－DPB1第二外显子基因序列与国际上公布的序列基本一致，但有不同之处，多处存在单核苷酸多态性（SNP），提示存在有新的等位基因。对51例个体研究显示，出现频率最高的等位基因是DPB1＊02012。     

Sequence-based typing of HLA class II DQB1

Due to the expanding number of known HLA class II DQB1 alleles, high-resolution oligotyping is becoming ineffective, therefore a sequence-based typing (SBT) strategy was developed to provide rapid and definitive typing of HLA-DQB1. HLA-DQB1*02, *03, *04, *05, and *06 alleles were individually amplified by polymerase chain reaction (PCR) using exon 2 group-specific primers. Forward and reverse PCR primers were tailed with M13 universal and M13 reverse sequences, respectively. Subsequent bi-directional cycle-sequencing was carried out using Cy5.5-labeled M13 universal primer and Cy5.0-labeled M13 reverse primer. Automated sequencing was performed in 30 min using a Visible Genetics, Inc. (VGI) MicroGene Clipper Sequencer. Full concordance was observed between this SBT method and oligotyping among 151 individuals.     

Highly polymorphic promoter regions of HLA DQA1 and DQB1 genes do not help to further define disease susceptibility in insulin-dependent diabetes mellitus

HLA DQA1, HLA DQB1 genes confer susceptibility to insulin-dependent (type 1) diabetes mellitus (IDDM). Since variants of their upstream regulatory regions are linked to the exons, we investigated their promoter polymorphisms (QAP and QBP) by a combination of PCR-based typing protocols in 136 IDDM patients, 167 controls and 6 families with an IDDM proband to identify possible additional susceptibility markers. Of major interest for IDDM susceptibility are the promoter "splits" of HLA DQA1*0301 (QAP3.1 and QAP3.2) and HLA DQB1*0302 (QBP3.2 and QBP3.3). QAP 3.1 (96% in patients vs 98% in controls) and QBP3.2 (100% vs 99%) were found to be the most frequent promoter variants for HLA DQA1*0301 and DQB1*0302, respectively, whereas QAP3.2 and QBP3.3 were very rare. Furthermore the promoter "splits" were equally distributed on the respective exon alleles in all groups and cosegregated in families as expected. In conclusion, HLA DQ-mediated susceptibility and protection in IDDM is not restricted to the exon but extends to the promoter region without further defining the genetic risk.     

血清阴性脊柱关节病与HLA-DRB1基因相关性研究

为探讨HLA DRB1基因与血清阴性脊柱关节病 (SpA )的相关性 ,我们采用PCR/SSO方法对上海地区 2 14例SpA患者及 15 0例随机正常对照、 13例B2 7阳性正常对照进行HLA DRB1基因分型。结果发现HLA DR12在病人组中明显高与正常对照组及B2 7阳性正常对照组 ,Pc =0 0 0 19,RR =1 988。DR6明显低于B2 7阳性对照组 ,P <0 0 0 5 ;DR6在B2 7阳性对照组中高于随机对照组 ,P <0 0 0 5。提示 ,上海地区SpA患者其DR12基因与B2 7之间可能存在连锁不平衡 ,并可能增加对SpA的易感性 ;而DR6则可能对SpA的易感有保护作用。